486 related articles for article (PubMed ID: 19073822)
1. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
Schreiber A; Xiao H; Jennette JC; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2009 Feb; 20(2):289-98. PubMed ID: 19073822
[TBL] [Abstract][Full Text] [Related]
2. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
[TBL] [Abstract][Full Text] [Related]
3. A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation.
Hao J; Wang C; Yuan J; Chen M; Zhao MH
PLoS One; 2013; 8(6):e66305. PubMed ID: 23785491
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
[TBL] [Abstract][Full Text] [Related]
5. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
6. Complement in ANCA-associated vasculitis.
Charles Jennette J; Xiao H; Hu P
Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
[TBL] [Abstract][Full Text] [Related]
7. C5a receptor (CD88) blockade protects against MPO-ANCA GN.
Xiao H; Dairaghi DJ; Powers JP; Ertl LS; Baumgart T; Wang Y; Seitz LC; Penfold ME; Gan L; Hu P; Lu B; Gerard NP; Gerard C; Schall TJ; Jaen JC; Falk RJ; Jennette JC
J Am Soc Nephrol; 2014 Feb; 25(2):225-31. PubMed ID: 24179165
[TBL] [Abstract][Full Text] [Related]
8. p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation.
Hao J; Meng LQ; Xu PC; Chen M; Zhao MH
PLoS One; 2012; 7(5):e38317. PubMed ID: 22675451
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor is involved in antineutrophil cytoplasmic antibody-mediated activation of C5a-primed neutrophils.
Hao J; Lv T; Xu L; Ran M; Wu K
BMC Immunol; 2019 Jun; 20(1):22. PubMed ID: 31248381
[TBL] [Abstract][Full Text] [Related]
10. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
Trivioli G; Vaglio A
Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis.
Schreiber A; Pham CT; Hu Y; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2012 Mar; 23(3):470-82. PubMed ID: 22241891
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis.
Schreiber A; Rolle S; Peripelittchenko L; Rademann J; Schneider W; Luft FC; Kettritz R
Kidney Int; 2010 Jan; 77(2):118-28. PubMed ID: 19907415
[TBL] [Abstract][Full Text] [Related]
13. Involvement of high mobility group box 1 in the activation of C5a-primed neutrophils induced by ANCA.
Wang C; Wang H; Hao J; Chang DY; Zhao MH; Chen M
Clin Immunol; 2015 Jul; 159(1):47-57. PubMed ID: 25934387
[TBL] [Abstract][Full Text] [Related]
14. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
15. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.
van Timmeren MM; van der Veen BS; Stegeman CA; Petersen AH; Hellmark T; Collin M; Heeringa P
J Am Soc Nephrol; 2010 Jul; 21(7):1103-14. PubMed ID: 20448018
[TBL] [Abstract][Full Text] [Related]
16. Complement system activation in ANCA vasculitis: A translational success story?
Kallenberg CG; Heeringa P
Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
[TBL] [Abstract][Full Text] [Related]
17. Involvement of protein kinase C in C5a-primed neutrophils for ANCA-mediated activation.
Hao J; Chen M; Zhao MH
Mol Immunol; 2013 May; 54(1):68-73. PubMed ID: 23201854
[TBL] [Abstract][Full Text] [Related]
18. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.
Xiao H; Heeringa P; Liu Z; Huugen D; Hu P; Maeda N; Falk RJ; Jennette JC
Am J Pathol; 2005 Jul; 167(1):39-45. PubMed ID: 15972950
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
20. Decoy nanoparticles bearing native C5a receptors as a new approach to inhibit complement-mediated neutrophil activation.
Li Y; Lin F
Acta Biomater; 2019 Nov; 99():330-338. PubMed ID: 31446047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]